Effective from 1 July 2020, pre-approval from Therapeutic Goods Administration (TGA) is not required for medicine advertisements in selected media.
The advertising of therapeutic goods will still be regulated by TGA
read more...Regulatory News
China to implement new Clinical Drug Quality Control Standards to harmonise GCP standards with ICH standards
In order to deepen the reform of the drug review and approval system, encourage innovation, and further promote the research and improvement of the quality of drug clinical trials in
read more...NPRA of Malaysia Issues Directive on Pre -Registration Test Results of Natural Products
On 12 May 2020. National Pharmaceutical Regulatory Division (NPRA) has issued a directive by the Director of Services Pharmacy pertaining to pre-registration test results of natural products from private laboratories.
Directive
read more...Malaysia Issues Directive for Physical Testing for Lot Release Activities for Vaccine and Plasma Products
On 12 May 2020, the National Pharmaceutical Regulatory Division (NPRA) of Malaysia has announced a directive by the Director of Pharmacy Services pertaining to physical testing for Lot release activities
read more...NMPA of China Releases Evaluation Guideline for Raw Material Changes in Passive Medical Devices
On 19 May 2020, the National Medical Products Administration(NMPA) of China has formulated a document to evaluate the changes in raw materials of passive medical device products.
A medical device that
read more...EPD Hong Kong Issues Guideline for Unserviceable / Expired Medicines
On May 2020, The Environmental Department (EPD) of Hong Kong has published a guideline with procedures on disposing of unserviceable or expired medicines for licensed pharmaceutical traders.
The pharmaceutical traders shall
read more...TGA Australia Updates Regulatory Guidelines In Replacement of ARGCM V8.0
The Therapeutic Goods Administration (TGA) of Australia has published in May 2020, new guidelines to replace the existing Australian Regulatory Guidelines for Complementary Medicines (ARGCM) V8.0 for registered complementary medicines
read more...China Issues Three Technical Guidelines for Consistency Evaluation of Generic Chemical Injections
On 15 May 2020, the Drug Evaluation Centre of China (CDE) has issued guidelines used to evaluate the consistency of efficacy and quality of generic chemical injections.
One of the guidelines
read more...Singapore publishes Summary Reports of Benefit-Risk Assessment for NCE/NBE online
Effective from June 2020 onward the Health Sciences Authority, Singapore will be publishing the Summary Reports of Benefit-Risk Assessments for new biological and chemical entities. The pilot initiative will boost
read more...